Ho, Chun-Te <br/><br/>
Folate deficiency-triggered redox pathways confer drug resistance in hepatocellular carcinoma.  [electronic resource] 

 -  Oncotarget  Sep 2015 
 - 26104-18 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.4422  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Carcinoma, Hepatocellular--genetics<br/>Catechin--analogs & derivatives<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Culture Media--metabolism<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Multiple--genetics<br/>Drug Resistance, Neoplasm--genetics<br/>Endoplasmic Reticulum Chaperone BiP<br/>Folic Acid--metabolism<br/>Heat-Shock Proteins--genetics<br/>Hep G2 Cells<br/>Humans<br/>Inhibitor of Apoptosis Proteins--genetics<br/>Liver Neoplasms--genetics<br/>Oxidation-Reduction<br/>RNA Interference<br/>Reactive Oxygen Species--metabolism<br/>Signal Transduction--drug effects<br/>Survivin